Among patients with MSS/MSI-L tumors, methylation was still associated with right-sided disease (p = 0.0125), higher-tumor grade (p < 0.0001), lymph node positivity (p = 0.0207), and BRAF mutation (p < 0.0001. The gene discussed is BRAF; the disease is neoplasm.